Drugs / Neurobion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04453761 | Jul 2018 → Dec 2021 | congenital heart disease, vitamin deficiency disorder | National Cardiovascular Center Harapan Kita Hospital Indonesia | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02150291 Comparator | May 2014 → May 2015 | hepatitis C virus infection | British University In Egypt | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neurobion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02150291 ↗ |
| Route | Intravenous | “Intravenous Thiamine 2 mg/kg in Neurobion injection” NCT04453761 ↗ |